These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 23330553

  • 1. The challenges of product- and process-related impurities to an evolving biopharmaceutical industry.
    Bracewell DG, Smales CM.
    Bioanalysis; 2013 Jan; 5(2):123-6. PubMed ID: 23330553
    [No Abstract] [Full Text] [Related]

  • 2. Biopharma deal-making in 2016.
    Micklus A, Muntner S.
    Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988
    [No Abstract] [Full Text] [Related]

  • 3. Chinese biotech hamstrung by production issues.
    Jia H.
    Nat Biotechnol; 2007 Feb; 25(2):147-8. PubMed ID: 17287733
    [No Abstract] [Full Text] [Related]

  • 4. Does chemistry have a future in therapeutic innovations?
    Meunier B.
    Angew Chem Int Ed Engl; 2012 Aug 27; 51(35):8702-6. PubMed ID: 22777842
    [No Abstract] [Full Text] [Related]

  • 5. Deal watch: Biopharma deal-making in 2015: changing the pharma landscape.
    Micklus A, Muntner S.
    Nat Rev Drug Discov; 2016 Feb 27; 15(2):78-9. PubMed ID: 26837586
    [No Abstract] [Full Text] [Related]

  • 6. The state of biopharmaceutical manufacturing.
    Molowa DT, Mazanet R.
    Biotechnol Annu Rev; 2003 Feb 27; 9():285-302. PubMed ID: 14650933
    [Abstract] [Full Text] [Related]

  • 7. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK.
    Nat Rev Drug Discov; 2014 Feb 27; 13(2):96-7. PubMed ID: 24481301
    [No Abstract] [Full Text] [Related]

  • 8. Russia through the prism of the world biopharmaceutical market.
    Bairamashvili DI, Rabinovich ML.
    Biotechnol J; 2007 Jul 27; 2(7):801-17. PubMed ID: 17615600
    [Abstract] [Full Text] [Related]

  • 9. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M, Nordström K.
    Eur J Pharm Biopharm; 2005 Apr 27; 59(3):397-405. PubMed ID: 15760720
    [Abstract] [Full Text] [Related]

  • 10. Biopharmaceutical proteins: opportunities and challenges.
    Birch JR, Onakunle Y.
    Methods Mol Biol; 2005 Apr 27; 308():1-16. PubMed ID: 16082021
    [No Abstract] [Full Text] [Related]

  • 11. Editorial: biopharmaceutical technologies.
    Jungbauer A.
    Biotechnol J; 2007 Jun 27; 2(6):647. PubMed ID: 17570696
    [No Abstract] [Full Text] [Related]

  • 12. 2011 in reflection.
    Mullard A.
    Nat Rev Drug Discov; 2012 Jan 03; 11(1):6-8. PubMed ID: 22212664
    [No Abstract] [Full Text] [Related]

  • 13. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI, Revel L, Rosa E, Cruces E.
    Drug News Perspect; 2009 Jan 03; 22(1):39-51. PubMed ID: 19209298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discovery pharmaceutics--challenges and opportunities.
    Chen XQ, Antman MD, Gesenberg C, Gudmundsson OS.
    AAPS J; 2006 Jun 02; 8(2):E402-8. PubMed ID: 16796392
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.